Health
Oxford Coronavirus vaccine update: Phase III trials to conclude by November, mass production expected by 2021 – Times of India
Oxford University backed vaccine is currently in its last stage of testing. The news follows after Russia successfully registered the world’s first COVID-19 vaccine, ‘Sputnik V’ after claiming decent results post completion of phase I.
The announcement also comes after SII head, Adar Poonawallah announced the availability of the vaccine for Indian masses by 2020. In an interview with a media agency recently, he spoke at length, saying:
“We are going to start trials in less than two weeks. The trial is in partnership with ICMR. We will start manufacturing vaccines by the end of August.”
According to revised proposals, the vaccine under the offering, which will be sold and marketed as ‘Covishield’ in India, will involve candid…
-
General15 hours agoWA Police investigate death of baby in Baldivis in Perth’s southern suburbs
-
Noosa News12 hours agoFatal e-bike crash, Mountain Creek (Sunshine Coast)
-
Noosa News21 hours agoBrisbane bus driver found guilty over CBD crash that killed Tia Cameron
-
Noosa News11 hours agoPrimary school boy dies following e-bike crash on the Sunshine Coast